Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Low-Intensity Versus Medium-Intensity Continuous Kidney Replacement Therapy for Critically Ill Patients (LIMIT): A Multicenter Randomized Clinical Trial

NCT06014801 is registered in ClinicalTrials.gov with Jikei University School of Medicine as lead sponsor.

NCT NCT06014801
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06014801 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Low-Intensity Versus Medium-Intensity Continuous Kidney Replacement Therapy for Critically Ill Patients (LIMIT): A Multicenter Randomized Clinical Trial
Lead sponsor
Jikei University School of Medicine
Phase
Phase 2/3
Overall status
Recruiting
Start date
October 30, 2023
Completion date
June 30, 2030
Enrollment
400 (estimated)
Sites
9

Conditions

As the registry lists them; a condition with its own page is linked.

acute kidney injury requiring continuous renal replacement therapy